Fmoc-leucine-d10 is a deuterated analog of Fmoc-leucine. Fmoc-leucine acts as a selective PPARγ modulator with lower potency but similar maximal efficacy compared to rosiglitazone in activating PPARγ. It improves insulin sensitivity in normal, diet-induced glucose-intolerant, and diabetic db/db mice, and exhibits reduced adipogenic activity.